Article Versions Notes

Guo L, Ge J, Miao M, Hu G, Wen J, Hu K, Ye G. Efficacy and Cost-Effectiveness of Vonoprazan–Amoxicillin Dual Therapy Versus Esomeprazole–Bismuth Quadruple Therapy for Helicobacter pylori: A Propensity Score-Matched Study. Microorganisms. 2026; 14(5):1006. https://doi.org/10.3390/microorganisms14051006

Guo, Lihua, Jiaxin Ge, Min Miao, Guimei Hu, Jinfeng Wen, Kefeng Hu, and Guoliang Ye. 2026. "Efficacy and Cost-Effectiveness of Vonoprazan–Amoxicillin Dual Therapy Versus Esomeprazole–Bismuth Quadruple Therapy for Helicobacter pylori: A Propensity Score-Matched Study" Microorganisms 14, no. 5: 1006. https://doi.org/10.3390/microorganisms14051006

Guo, L., Ge, J., Miao, M., Hu, G., Wen, J., Hu, K., & Ye, G. (2026). Efficacy and Cost-Effectiveness of Vonoprazan–Amoxicillin Dual Therapy Versus Esomeprazole–Bismuth Quadruple Therapy for Helicobacter pylori: A Propensity Score-Matched Study. Microorganisms, 14(5), 1006. https://doi.org/10.3390/microorganisms14051006